TUBERCULOSIS VERSUS VASCULITIS

Authors

  • Zahid Farooq Baig
  • Khalid Mahmood Raja
  • Fahad Abbas

Abstract

Vasculitis (Wegeners Granulomatosis and Microscopic Polyangiitis) and Tuberculosis share many features including constitutional symptoms and respiratory tract involvement. The presence of kidney involvement with new onset azotaemia and active urine sediment support the diagnosis of vasculitis. We describe two cases that were diagnosed to be suffering from tuberculosis and placed on anti-tuberculosis therapy. On further workup they were found to be suffering from pauci-immune glomerulonephritis and recovered well with treatment.Keywords: Tuberculosis, Microscopic polyangiitis, Wegener’s granulomatosis, ANCA-associated vasculitis

References

Gutierrez M, Brisse S, Brosch R, Fabre M, Omaïs M, Marmiesse M, et al. Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLoS Pathog 2005;1:e5.

Hershkovitz I, Donoghue H, Minnikin D, Besra GS, Lee OY, Gernaey AM, et al. Detection and molecular characterization of 9000-year-old Mycobacterium tuberculosis from a Neolithic settlement in the eastern Mediterranean. PLoS One 2008;3(10):e3426.

Stumpe KD, Dazzi H, Schaffner A, von Schulthess GK. Infection imaging using whole-body FDG-PET. Eur J Nucl Med 2000;27:822–32.

Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum: 1994;37:187–92.

Luqmani R, Sheeran T, Robinson M, Richardson K, Winkles J, Emery P. Systemic cytokine measurements: their role in monitoring the response to therapy in patients with rheumatoid arthritis. Clin Exp Rheumatol 1994;12:503–8.

De Groot K, Gross WL, Herlyn K, Reinhold-Keller E. Development and validation of a disease extent index for Wegener's granulomatosis. Clin Nephrol 2001;55:31–8.

Van der Woude FJ, Rasmussen N, Lobatto S, Wiik A, Permin H, van Es LA, et al. Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;1(8426):425–9.

Seo P, Stone JH. The antineutrophil cytoplasmic antibody-associated vasculitides. Am J Med 2004;117:39-50.

Hoffman GS, Kerr GS, Leavitt RY, Hallahan C, Lebovics RS, Travis CW, et al. Wegener's granulomatosis: An analysis of 158 patients. Ann Intern Med 1992;116:488–98.

Langford CA. Treatment of ANCA-associated vasculitis. N Engl J Med 2003;349:3-4.

Nachman PH, Hogan SL, Jennette JC, Falk RJ. Treatment response and relapse in antineutrophil cytoplasmic antibody-associated microscopic polyangiitis and glomerulonephritis. J Am Soc Nephrol 1996;7:33–9.

Andrassy K, Erb A, Koderisch J, Waldherr R, Ritz E. Wegener's granulomatosis with renal involvement: Patient survival and correlations between initial renal function, renal histology, therapy and renal outcome. Clin Nephrol 1991;35:139–47.

Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniené J, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 2003;349:36–44.

Langford CA, Talar-Williams C, Sneller MC. Use of methotrexate and glucocorticoids in the treatment of Wegener's granulomatosis. Long-term renal outcome in patients with glomerulonephritis. Arthritis Rheum 2000;43:1836–40

Published

2014-12-01